Top
Topic: Advances in DNA Damage & Repair and Cancer Drug Resistance

A special issue of Cancer Drug Resistance.

ISSN 2578-532X (Online)

Submission deadline: 31 Aug 2020

Guest Editor(s)

  • Dr. Eddy S. Yang
    Hazelrig Salter Radiation Oncology Center, 1700 6th Avenue South Birmingham, AL 35233, USA

    Website | E-mail

  • Dr. Robert C.A.M. van Waardenburg
    VH 155, VOLKER HALL, Birmingham, AL 35294-0019, USA

    Website | E-mail

Special Issue Introduction

With the recent clinical successes of the PARP inhibitors, the DNA repair pathways have come to the forefront as a bona fide target for personalized treatment of cancers with defective homologous recombination repair. Additionally, DNA repair (genome instability) is a well-established hallmark of cancer and can be a means for dictating tumor sensitivity and resistance to traditional treatments such as chemotherapy and radiation. In this special issue, we will provide a basic, translational, and clinical overview of the interactions of the various DNA repair pathways as it relates to carcinogenesis, treatment, and biomarker of response.

Keywords

DNA damage response pathways, DNA repair pathways, Cellular response to chemotherapeutics, DNA damage response/repair inhibitors, Combination Therapy, Genome instability, Immunotherapy

Submission Deadline

31 Aug 2020

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://cdrjournal.com/pages/view/author_instructions
For Online Submission, please login at https://www.oaemesas.com/cdr
Submission Deadline: 31 Aug 2020
Contacts: Susan Song, Assistant Editor, Susan@cdrjournal.com

Published Articles

This special issue is now open for submission.